EE379 Potential Healthcare Resource Use and Associated Costs of Every 2-Months Injectable Cabotegravir+Rilpivirine Long-Acting Implementation in the Spanish NHS vs Daily Oral HIV Treatments

Autor:	LA Vallejo-Aparicio, V Neches, B Hernández Novoa, G Casado, F Jodar, M Pinel, D Callejo-Velasco
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S129-S130
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.625
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::43420be098adf12adab2e48ef94fdce0 https://doi.org/10.1016/j.jval.2022.09.625 Zobrazit plný text záznamu Full Text from ScienceDirect